Starpharma Holdings Ltd (AU:SPL) — Market Cap & Net Worth

$273.41 Million USD · AU$386.41 Million AUD · Rank #15400

Market Cap & Net Worth: Starpharma Holdings Ltd (SPL)

Starpharma Holdings Ltd (AU:SPL) has a market capitalization of $273.41 Million (AU$386.41 Million) as of September 24, 2026. Listed on the AU stock exchange, this Australia-based company holds position #15400 globally and #411 in its home market, demonstrating a 9.46% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Starpharma Holdings Ltd's stock price AU$0.81 by its total outstanding shares 477054949 (477.05 Million). Also see SPL asset base for a full breakdown of the balance sheet.

Starpharma Holdings Ltd Market Cap History: 2015 to 2026

Starpharma Holdings Ltd's market capitalization history from 2015 to 2026. Data shows growth from $253.16 Million to $273.41 Million (1.08% CAGR). Also see cash efficiency ratio of Starpharma Holdings Ltd for how efficiently the company converts equity into cash flow.

Index Memberships

Starpharma Holdings Ltd is a constituent of 1 market index:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Australia All Ordinaries AORD	$1.97 Trillion	0.01%	#264 of 495

Weight: Starpharma Holdings Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Starpharma Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Starpharma Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Starpharma Holdings Ltd share price for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

22.69x

Starpharma Holdings Ltd's market cap is 22.69 times its annual revenue

Industry average: 3974.70x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2017	$459.06 Million	$3.65 Million	-$15.22 Million	125.87x	N/A
2018	$399.99 Million	$4.96 Million	-$10.29 Million	80.69x	N/A
2019	$408.43 Million	$2.72 Million	-$14.25 Million	150.16x	N/A
2020	$528.26 Million	$6.03 Million	-$14.68 Million	87.56x	N/A
2021	$452.31 Million	$1.80 Million	-$19.73 Million	251.56x	N/A
2022	$185.65 Million	$4.68 Million	-$16.15 Million	39.65x	N/A
2023	$57.38 Million	$2.94 Million	-$15.64 Million	19.52x	N/A
2024	$37.13 Million	$8.29 Million	-$8.16 Million	4.48x	N/A
2025	$121.52 Million	$4.91 Million	-$9.99 Million	24.74x	N/A
2026	$273.41 Million	$12.05 Million	-$7.46 Million	22.69x	N/A

Competitor Companies of SPL by Market Capitalization

Companies near Starpharma Holdings Ltd in the global market cap rankings as of September 24, 2026. Review Starpharma Holdings Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Starpharma Holdings Ltd by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #187 globally with a market cap of $130.53 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #334 globally with a market cap of $80.46 Billion USD.
CSL Ltd (AU:CSL): Ranked #451 globally with a market cap of $62.04 Billion USD ( AU$87.68 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #510 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#187	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.53 Billion	$514.99
#334	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$80.46 Billion	$803.90
#451	CSL Ltd	AU:CSL	$62.04 Billion	AU$180.72
#510	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$182.56

Starpharma Holdings Ltd Historical Marketcap From 2015 to 2026

Between 2015 and today, Starpharma Holdings Ltd's market cap moved from $253.16 Million to $ 273.41 Million, with a yearly change of 1.08%.

Year	Market Cap	Change (%)
2026	AU$273.41 Million	+125.00%
2025	AU$121.52 Million	+227.27%
2024	AU$37.13 Million	-35.29%
2023	AU$57.38 Million	-69.09%
2022	AU$185.65 Million	-58.96%
2021	AU$452.31 Million	-14.38%
2020	AU$528.26 Million	+29.34%
2019	AU$408.43 Million	+2.11%
2018	AU$399.99 Million	-12.87%
2017	AU$459.06 Million	+87.59%
2016	AU$244.72 Million	-3.33%
2015	AU$253.16 Million	--

End of Day Market Cap According to Different Sources

On Sep 23rd, 2026 the market cap of Starpharma Holdings Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$273.41 Million USD
MoneyControl	$273.41 Million USD
MarketWatch	$273.41 Million USD
marketcap.company	$273.41 Million USD
Reuters	$273.41 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Starpharma Holdings Ltd

AU:SPL Australia Biotechnology

Market Cap

$273.41 Million

AU$386.41 Million AUD

Market Cap Rank

#15400 Global

#411 in Australia

Share Price

AU$0.81

Change (1 day)

+1.89%

52-Week Range

AU$0.22 - AU$0.81

All Time High

AU$2.49